跳至主要内容
临床试验/NCT02566499
NCT02566499撤回不适用

Performance Assessment of a First Generation Breast Microwave Imaging System: Study of Breast Abnormalities Detection

University of Manitoba0 个研究点开始时间: 2018年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
主要终点
Diagnostic Accuracy (NO units)

研究概览

简要总结

The main goal of this project is to assess the ability of a recently developed Breast Microwave Imaging (BMI) system to detect abnormalities in a human breast. These trials will be performed by recruiting fourteen volunteers that have been diagnosed with breast abnormalities using x-ray mammography. The breast presenting the abnormality will be imaged using the BMI system in a controlled and comfortable environment. As this is a feasibility study of the technology, and has the main goal to evaluate the diagnostic accuracy of this technology. The data collected from this study will be used to: (1) evaluate the overall participant experience during the BMI imaging procedure, (2) optimize the design of the BMI imaging system (both hardware and software), (3) open discussions with other medical professionals (e.g. radiologists) about the clinical feasibility of this emerging diagnostic imaging modality.

详细描述

The Breast Microwave Imaging (BMI) system that will be used in this study is designed to detect breast abnormalities using low power microwave waveforms. The system is formed by three main components:

  1. Patient bed. The volunteer will be positioned in this bed in a prone position where with the breast to be imaged in a pendant position.
  2. Instrumentation rack. This component contains all the microwave instrumentation and motion mechanisms required to illuminate the breast using an ultrawide band waveform and record the responses from the breast structures.
  3. Control computer. This component is used to control the motion of the mechanical components of the system and to retrieve the responses from the breast structures from the microwave instruments and store them in an electronic format.

The system takes between 7.5 to 10 minutes to collect a three dimensional dataset from a single breast.

The BMI system used in the study operates in the frequency range of 20 megahertz (MHz) to 9 gigahertz (GHz). Canadian safety limits for the interaction of these non-ionizing electromagnetic waves with humans are outlined in the Health Canada publication "Safety Code 6: Limits of Human Exposure to Radiofrequency Electromagnetic Energy in the Frequency Range from 3 kilohertz (kHz) to 300 GHz [1]. For unregulated environments, the Specific Absorption Rate (SAR) limit set by Health Canada is 1.6 W/Kg. In the system used in this study, radio-frequency energy is generated via the Vector Network Analyzer (VNA). If the VNA is set at its maximum output power, which is 3.2 milliwatt (mW), the power received at 5 cm from the antenna (which is the distance where the breast will be) was measured to be 890 microwatt, which would yield a SAR value of 0.0196 W/kg.

References

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
40 Years 至 85 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • The volunteers must be at least 40 years old.
  • The volunteers should have been diagnosed with a breast abnormality using x-ray mammography within the preceding two months.

排除标准

  • The volunteers should not have breast implants.
  • The volunteers should have not yet had a biopsy.

研究组 & 干预措施

Abnormal x-ray Mammography group

Experimental

A Breast Microwave Imaging Procedure will be carried out on volunteers who have abnormal x-ray mammograms, prior to the volunteer undergoing a biopsy to confirm diagnosis (as part of their normal care).

干预措施: Breast Microwave Imaging (Device)

结局指标

主要结局

Diagnostic Accuracy (NO units)

时间窗: 1 year

Diagnostic Accuracy = (TP+TN)/(TP+FP+FN+TN): The fraction of patients that are diagnosed accurately, which is in turn a function of the Sensitivity and Specificity of the test. Sensitivity: The probability that a test result will be positive when the disease is present (true-positive fraction) = TP/(TP+FN) Specificity: The probability that a test result will be normal when the disease is absent (true-negative fraction) = TN/(FP+TN) TP = True Positive TN = True Negative FP = False Positive FN = False Negative

次要结局

  • Sensitivity (NO units)(1 year)
  • Specificity (NO units)(1 year)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Performance Assessment of a First Generation Breast... | 临床试验